Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon disposes of 1,540 common shares worth $175,806.40 - CORT News | RalliesCorcept Chief Accounting & Technology Officer Joseph Douglas Lyon disposes of 1,540 common shares worth $175,806.40
C
CORT• Insider share sale
- Corcept Therapeutics Chief Accounting & Technology Officer Joseph Douglas Lyon sold 1,540 common shares on Aug. 3, 2026.
- Shares were sold at $114.16, leaving him with 5,495 shares beneficially owned.
AEE
•
